Natco Pharma API plant hit with Form 483
Natco Pharma has received a Form 483 with six observations from the U.S. FDA for the drugmaker ' s active pharmaceutical ingredient facility located outside Hyderabad, India.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: India Health | Pharmaceuticals